These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 8182812

  • 1. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
    Pittet D, Tarara D, Wenzel RP.
    JAMA; 1994 May 25; 271(20):1598-601. PubMed ID: 8182812
    [Abstract] [Full Text] [Related]

  • 2. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.
    Digiovine B, Chenoweth C, Watts C, Higgins M.
    Am J Respir Crit Care Med; 1999 Sep 25; 160(3):976-81. PubMed ID: 10471627
    [Abstract] [Full Text] [Related]

  • 3. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
    Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP.
    JAMA; 1999 Sep 25; 277(4):301-6. PubMed ID: 9002492
    [Abstract] [Full Text] [Related]

  • 4. Cost of intensive care unit-acquired bloodstream infections.
    Laupland KB, Lee H, Gregson DB, Manns BJ.
    J Hosp Infect; 2006 Jun 25; 63(2):124-32. PubMed ID: 16621137
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.
    Wisplinghoff H, Cornely OA, Moser S, Bethe U, Stützer H, Salzberger B, Fätkenheuer G, Seifert H.
    Infect Control Hosp Epidemiol; 2003 Dec 25; 24(12):905-11. PubMed ID: 14700405
    [Abstract] [Full Text] [Related]

  • 6. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
    Orsi GB, Di Stefano L, Noah N.
    Infect Control Hosp Epidemiol; 2002 Apr 25; 23(4):190-7. PubMed ID: 12002233
    [Abstract] [Full Text] [Related]

  • 7. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.
    Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ.
    Infect Control Hosp Epidemiol; 1999 Nov 25; 20(11):725-30. PubMed ID: 10580621
    [Abstract] [Full Text] [Related]

  • 8. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
    Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ.
    Crit Care Med; 2006 Aug 25; 34(8):2084-9. PubMed ID: 16763511
    [Abstract] [Full Text] [Related]

  • 9. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay.
    Rosenthal VD, Guzman S, Orellano PW.
    Am J Infect Control; 2003 Aug 25; 31(5):291-5. PubMed ID: 12888765
    [Abstract] [Full Text] [Related]

  • 10. Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality.
    Liu JW, Su YK, Liu CF, Chen JB.
    J Hosp Infect; 2002 Mar 25; 50(3):224-7. PubMed ID: 11886200
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and extension of hospital stay.
    Tumbarello M, Tacconelli E, Donati KG, Leone F, Morace G, Cauda R, Ortona L.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 15; 19(5):490-7. PubMed ID: 9859963
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Nosocomial bacteremia in the adult patient. Study of associated costs].
    Morano Amado LE, Del Campo Pérez V, López Miragaya I, Martínez Vázquez MJ, Vázquez Alvarez O, Pedreira Andrade JD.
    Rev Clin Esp; 2002 Sep 15; 202(9):476-84. PubMed ID: 12236937
    [Abstract] [Full Text] [Related]

  • 15. Hospital-acquired candidemia. The attributable mortality and excess length of stay.
    Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP.
    Arch Intern Med; 1988 Dec 15; 148(12):2642-5. PubMed ID: 3196127
    [Abstract] [Full Text] [Related]

  • 16. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study.
    Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S.
    Infect Control Hosp Epidemiol; 1999 Jun 15; 20(6):396-401. PubMed ID: 10395140
    [Abstract] [Full Text] [Related]

  • 17. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients.
    García-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jiménez FJ, Monterrubio-Villar J, Gili-Miner M.
    Crit Care Med; 1999 Sep 15; 27(9):1794-9. PubMed ID: 10507600
    [Abstract] [Full Text] [Related]

  • 18. Impact of nosocomial infections on medical costs, hospital stay, and outcome in hospitalized patients.
    Sheng WH, Chie WC, Chen YC, Hung CC, Wang JT, Chang SC.
    J Formos Med Assoc; 2005 May 15; 104(5):318-26. PubMed ID: 15959598
    [Abstract] [Full Text] [Related]

  • 19. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis.
    Rosenthal VD, Guzman S, Migone O, Crnich CJ.
    Am J Infect Control; 2003 Dec 15; 31(8):475-80. PubMed ID: 14647110
    [Abstract] [Full Text] [Related]

  • 20. Healthcare-Associated Infections Due to Multidrug-Resistant Organisms: a Surveillance Study on Extra Hospital Stay and Direct Costs.
    Giraldi G, Montesano M, Napoli C, Frati P, La Russa R, Santurro A, Scopetti M, Orsi GB.
    Curr Pharm Biotechnol; 2019 Dec 15; 20(8):643-652. PubMed ID: 30961489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.